DRCT Earnings

DRCT reported its FY2025Q3 earnings on 2025-11-06, showcasing a revenue of 8.00M against an estimate of 15.00M, resulting in a -44.94% surprise. The EPS was -0.24, surpassing the expected -0.16 by -50% . The stock experienced a -34.56% price change on the earnings day and a -37.07% change over the next five days, reflecting market reactions to the results.

Following DRCT's FY2025Q3 earnings announcement on 2025-11-06, the stock price moved by -34.56% on the day of the release. Over the subsequent five days, it saw a -37.07% change. Historically, DRCT's stock price tends to shift by an average of -8.98% in the 10 days leading up to earnings and -4.51% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate DRCT’s annual revenue to reach 8.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -0.13% and EPS estimates Revise Downward by -0.56% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between DRCT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -0.13%, while EPS estimates moved Revise Downward by -0.56% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, DRCT's stock price typically moves by -8.98% in the 10 days before its earnings and -4.51% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 8.00M.

The earnings call reveals a mixed financial performance with declining consolidated revenue and gross margin, despite a slight improvement in net loss. The Q&A highlights strategic partnerships and a shift to larger customers, but these positives are overshadowed by significant revenue attrition and vague management responses. The focus on a new platform and ecosystem approach is promising but still in early stages, posing risks. The market may react negatively due to unclear financial guidance and ongoing challenges, particularly in the sell-side business.